Healthcare • Biotechnology
EODHD (TTM) · as of Nov 6, 2026
End-of-day close from stored market data, not a live quote.
CervoMed Inc., a clinical-stage biotechnology company, engages in the development and commercialization of treatments for age-related neurologic disorders. The company is developing neflamapimod, an orally administered small molecule drug that crosses the blood"brain barrier and inhibits the enzyme p38a.
Neflamapimod has the potential to reverse synaptic dysfunction, improve neuron health, and slow or prevent disease progression. Neflamapimod is currently in clinical development for the treatment of dementia with Lewy bodies, non-fluent variant primary progressive aphasia, amyotrophic lateral sclerosis, and amyotrophic lateral sclerosis. CervoMed Inc. was founded in 2010 and is headquartered in Boston, Massachusetts.
Company profile from EODHD, stored Oct 25, 2026.
The last 8 fiscal quarters as reported (EODHD). Year over year compares the same quarter a year earlier.
| Quarter | Revenue | YoY | Gross margin | Op. income | Net income |
|---|---|---|---|---|---|
| Jun 2026filed Aug 7, 2026 | — | — | — | -$6.7M | -$6.6M |
| Mar 2026filed May 15, 2026 | — | — | — | -$8.1M | -$8.0M |
| Dec 2025filed Mar 13, 2026 | $8.7K | -99.6% | — | -$8.3M | -$8.1M |
| Sep 2025filed Nov 7, 2025 | $322.6K | -83.4% | 100.0% | -$8.0M | -$7.7M |
| Jun 2025filed Aug 8, 2025 | $1.8M | -46.6% | -190.6% | -$6.6M | -$6.3M |
| Mar 2025filed May 12, 2025 | $1.9M | -18.3% | -152.3% | -$5.3M | -$4.9M |
| Dec 2024filed Mar 17, 2025 | $2.2M | -13.2% | -227.8% | -$7.2M | -$6.7M |
| Sep 2024filed Nov 12, 2024 | $1.9M | +27.1% | -164.2% | -$5.4M | -$4.8M |
FINRA reports open short positions for a settlement date. The publication date is later. These are reported positions, with a separate date for each observation.
Compare the reported short exposure around the dates you bought, sold or watched CRVO. A long position benefits from price rises; a short position benefits from falls. A change in these counts does not predict either move.
Settlement Oct 15, 2026
1,208,132 shares short
-131,639 shares (-9.8%) vs Sep 30, 2026
12.6% of the stored float. Published Oct 26, 2026.
Settlement Sep 30, 2026
1,339,771 shares short
+111,853 shares (+9.1%) vs Sep 15, 2026
13.9% of the stored float. Published Oct 9, 2026.
Settlement Sep 15, 2026
1,227,918 shares short
-101,725 shares (-7.7%) vs Aug 31, 2026
20.3% of the stored float. Published Sep 24, 2026.
Settlement Aug 31, 2026
1,329,643 shares short
+367,067 shares (+38.1%) vs Aug 14, 2026
Share of float unavailable. Published Sep 10, 2026.
Settlement Aug 14, 2026
962,576 shares short
+130,151 shares (+15.6%) vs Jul 31, 2026
Share of float unavailable. Published Aug 25, 2026.
Settlement Jul 31, 2026
832,425 shares short
+4,970 shares (+0.6%) vs Jul 15, 2026
Share of float unavailable. Published Aug 11, 2026.
Change = this settlement’s shares short − the previous recorded settlement’s shares short; percentage change divides by that earlier count. A zero earlier count has no percentage change. Split-spanning counts are left uncompared. Float percentages use the stored settlement observation, not today’s float.
Source: stored FINRA equity short-interest records, up to six settlements from the last 240 days. FINRA data and reporting dates · How to read short interest
See the recorded cash amounts and dates behind CRVO’s income, and the splits that change its share count. Dates below are stored event records, not confirmation of a payment to your account.
No qualified cash-dividend records are stored. This does not establish that the company pays no dividend.
Up to six Polygon cash-dividend events, including recorded ex-dates within the next 120 days. Amounts retain their recorded currency and decimal precision. Historical amounts are not restated to a common split basis, annualized, or converted to dollars.
For a long holding, compare the ex-date with when you held the shares and check the pay date against your broker’s cash history. Owning the stock today does not establish past entitlement. For a short holding, a dividend can create a payment obligation to the share lender.
Ex-dates and special dividend rules · Short-sale dividend obligations · Dividend data definitions
2 for 3 · reverse split
Effective Aug 17, 2023
Each 3 pre-split shares become 2 post-split shares.
Source: EODHD
1 for 50 · reverse split
Effective Apr 19, 2022
Each 50 pre-split shares become 1 post-split share.
Source: EODHD
1 for 15 · reverse split
Effective Dec 14, 2018
Each 15 pre-split shares become 1 post-split share.
Source: EODHD
1 for 10 · reverse split
Effective Aug 19, 2016
Each 10 pre-split shares become 1 post-split share.
Source: EODHD
1 for 100 · reverse split
Effective Mar 10, 2014
Each 100 pre-split shares become 1 post-split share.
Source: EODHD
Up to six stored split dates through Nov 7, 2026. Equivalent vendor ratios are combined; conflicting ratios are left out. This history may be incomplete.
A split changes the share count and per-share price basis; it does not by itself add investment value. Put your holding’s earlier and later share counts on the same basis before comparing them. This applies to both long shares and shares owed on a short position.
How stock splits workSign in to see your position size
We’ll show you if CRVO is in your portfolio and how much it contributes.
Sign inLoading market dates
7 smart-money holders: institutions with a high Holder IQ
Sentiment: unknown
No recent insider trades detected.
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
Red flags: 6
Sign in to read your holdings or watchlist context. No personal position or direction is inferred.
No directional recent-activity label is available. This context label is separate from the scored insider signal read.
A count of reported activity describes a sample, not purchase conviction, an insider’s intent or a future price move. Neutral is not an all-clear, and absent direction is not neutral evidence.
The current context rule reads at most 50 nonduplicate issuer/share-class records filed in the last 90 days. It counts a bullish direction or purchase code P toward bullish, and a bearish direction or sale code S toward bearish. A side must exceed the opposite count by more than two to set its label; otherwise nonzero directional counts produce neutral. Calculation unavailable for this saved label: its counts, exact records, as-of time and rule version are not supplied here. Do not substitute the separate scored read’s different window or denominator.
Stored SEC Forms 3/4/5 insider-signal records, ordered by filing date with amendment duplicates excluded. Filing date is not transaction date. The last-trade line locates recent reported activity; it does not date or reconstruct the complete count.
37 filers reported a long position in CRVO for Q2 2026. 13-F holdings are filed up to 45 days after the quarter ends.
The top 10 hold
89.4%
of the 1.7M shares 13-F filers reported
Moves vs Q1 2026
4 added1 trimmed
2 new · 3 unchanged
Net shares held
+11.6%
across the 8 holders with a comparable Q1 2026 book
| Rank | Holder | Value | Shares | Shares vs Q1 2026 |
|---|---|---|---|---|
| 1 | Woodline Partners LP | $2.1M · 689K shares | 689K | New |
| 2 | VANGUARD CAPITAL MANAGEMENT LLC | $980.2K · 316.2K shares | 316.2K | Unchanged |
| 3 | SABBY MANAGEMENT, LLC | $771.5K · 248.9K shares | 248.9K | New |
| 4 | GEODE CAPITAL MANAGEMENT, LLC | $207.5K · 66.9K shares | 66.9K | -10% |
| 5 | BlackRock, Inc. | $166.9K · 53.8K shares | 53.8K | +4.2% |
| 6 | Byrne Asset Management LLC | $158.9K · 51.3K shares | 51.3K | +248.6% |
| 7 | CITIZENS FINANCIAL GROUP INC/RI | $116.2K · 37.5K shares | 37.5K | Unchanged |
| 8 | VANGUARD FIDUCIARY TRUST CO | $112.1K · 36.2K shares | 36.2K | Unchanged |
| 9 | JANE STREET GROUP, LLC | $99.9K · 32.2K shares | 32.2K | +76.6% |
| 10 | THOMPSON DAVIS & CO., INC. | $92.2K · 29.8K shares | 29.8K | +197.5% |
Sign in to see each holder’s Holder IQ, factor-adjusted Holder IQ and rank, and compare these holders with all scored filers. Available on every plan.
Sign inHolders of more than 5% of CRVO file with the SEC within days. A 13D holder may seek to influence the company; a 13G holder is passive. Each holder’s latest filing from the last three years.
| Filed | Holder | % of class |
|---|---|---|
| Aug 14, 2026 | CVI Investments Inc13G · passive · amended | 0%under 5% |
| Aug 14, 2026 | RA CAPITAL MANAGEMENT, L.P.13G · passive · amended | 8.6% |
| Aug 14, 2026 | ARMISTICE CAPITAL, LLC13G · passive | 9.53% |
| Aug 14, 2026 | Woodline Partners LP13G · passive | 5.1% |
| Jul 8, 2026 | MORGAN STANLEY13G · passive · amended | 0.1%under 5% |
| Jun 15, 2026 | BOGER JOSHUA S13D · activist · amended | 20% |
| Apr 7, 2026 | AWM Investment Company, Inc.13G · passive · amended | 4.2%under 5% |
Unlock detailed insider transactions, institutional holder changes, factor exposures, and personalized alerts. Start free with your own portfolio.